Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Acotec/Boston Scientific: Even Higher Proration

Acotec (6669 HK): Boston Scientific's Partial Offer Open For Tendering

Acotec (6669 HK): Current Proration of 82.7%

Acotec (先瑞达) IPO Trading: Expect Poor Debut Performance

Acotec (先瑞达) IPO: Risk-Reward Does Not Warrant Participation

Acotec (先瑞达) Pre-IPO: Thoughts on Valuation

Quiddity Advisors

Event-Driven

Acotec Scientific Holdings / Event-Driven

<ul>
<li>
<strong><a href="https://www.smartkarma.com/entities/acotec-scientific-holdings-limited" target="_blank" data-smartkarma-citation="entities:32176:1" rel="noopener">Acotec Scientific Holdings (6669 HK)</a></strong>, a Chinese medical technology company, has <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2022/1212/2022121200003.pdf" target="_blank" rel="noopener">announced</a> a Partial Offer from <strong><a href="https://www.smartkarma.com/entities/boston-scientific-corp" target="_blank" data-smartkarma-citation="entities:11115:1" rel="noopener">Boston Scientific (BSX US)</a></strong>.</li>
<li>The Offer Price for up to 65% of shares out is HK20/share, a 31.6% premium to last close, but below last year's IPO price of HK$23.80/share. </li>
<li>Irrevocables who intend to tender a total of up to 60.14% of shares out. This includes the CEO and the key pre-IPO investor. </li>
</ul>



Acotec Scientific Holdings (6669 HK), a Chinese medical technology company, has announced a Partial Offer from Boston Scientific (BSX US).
The Offer Price for up to 65% of shares out is HK20/share, a 31.6% premium to last close, but below last year's IPO price of HK$23.80/share. 
Irrevocables who intend to tender a total of up to 60.14% of shares out. This includes the CEO and the key pre-IPO investor. 


Acotec Scientific Holdings: Boston Scientific's Partial Offer